---
$id: https://graph.org.ai/products/commodity/51142537
$type: Product
source: UNSPSC
code: "51142537"
title: "Piroheptine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piroheptine

**UNSPSC Code**: 51142537
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C22H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AR6Y753ARL, chemically known as 3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine but generally known as piroheptine, which bears US NIH Compound Identifier 4854. European Medicines Agency schedules Piroheptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09931MIG. The term PIROHEPTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). PIROHEPTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piroheptine under HS 29339990 and SITC 51577. As of Q4 2014, PIROHEPTINE remains the US FDA Preferred Term for this commodity. Piroheptine bears US NLM identifiers UMLS ID C0071147 and NCI Concept Code C66431. SMILES: N1(C(/C(=C2/C3C(CCC4C2CCCC4)CCCC3)CC1)C)CC.

